The strength–risk continuum: reframing muscular weakness as a clinically relevant risk marker

Avery D Faigenbaum, James P MacDonald, Arnaldo Mortatti, Emilio Villa-González, Tamara Rial Rebullido

Open source

DOI
10.1136/bjsports-2026-112013
Published
2026-09-17
Container
British Journal of Sports Medicine
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bjsports-2026-112013,
  title = {The strength–risk continuum: reframing muscular weakness as a clinically relevant risk marker},
  author = {Avery D Faigenbaum and James P MacDonald and Arnaldo Mortatti and Emilio Villa-González and Tamara Rial Rebullido},
  year = {2026},
  journal = {British Journal of Sports Medicine},
  doi = {10.1136/bjsports-2026-112013},
  url = {https://doi.org/10.1136/bjsports-2026-112013}
}

RIS

TY  - JOUR
TI  - The strength–risk continuum: reframing muscular weakness as a clinically relevant risk marker
AU  - Avery D Faigenbaum
AU  - James P MacDonald
AU  - Arnaldo Mortatti
AU  - Emilio Villa-González
AU  - Tamara Rial Rebullido
PY  - 2026
JO  - British Journal of Sports Medicine
DO  - 10.1136/bjsports-2026-112013
UR  - https://doi.org/10.1136/bjsports-2026-112013
ER  - 

APA

Faigenbaum, A. D., MacDonald, J. P., Mortatti, A., Villa-González, E., & Rebullido, T. R. (2026). The strength–risk continuum: reframing muscular weakness as a clinically relevant risk marker. British Journal of Sports Medicine. https://doi.org/10.1136/bjsports-2026-112013

Source records